BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23082981)

  • 1. Targeting the nuclear transport machinery by rational drug design.
    Mao L; Yang Y
    Curr Pharm Des; 2013; 19(12):2318-25. PubMed ID: 23082981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection.
    Lu C; Figueroa JA; Liu Z; Konala V; Aulakh A; Verma R; Cobos E; Chiriva-Internati M; Gao W
    Curr Cancer Drug Targets; 2015; 15(7):575-92. PubMed ID: 26324128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells.
    Niu M; Chong Y; Han Y; Liu X
    Cancer Biol Ther; 2015; 16(7):1110-8. PubMed ID: 25996664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents.
    Turner JG; Dawson J; Cubitt CL; Baz R; Sullivan DM
    Semin Cancer Biol; 2014 Aug; 27():62-73. PubMed ID: 24631834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Exportin-1 is a Target for Combined Therapy of HIV and AIDS Related Lymphoma.
    Boons E; Vanstreels E; Jacquemyn M; Nogueira TC; Neggers JE; Vercruysse T; van den Oord J; Tamir S; Shacham S; Landesman Y; Snoeck R; Pannecouque C; Andrei G; Daelemans D
    EBioMedicine; 2015 Sep; 2(9):1102-13. PubMed ID: 26501108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein.
    Ishizawa J; Kojima K; Hail N; Tabe Y; Andreeff M
    Pharmacol Ther; 2015 Sep; 153():25-35. PubMed ID: 26048327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XPO1-dependent nuclear export as a target for cancer therapy.
    Azizian NG; Li Y
    J Hematol Oncol; 2020 Jun; 13(1):61. PubMed ID: 32487143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome Region Maintenance 1 (XPO1/CRM1) as an Anticancer Target and Discovery of Its Inhibitor.
    Liu S; Qiao W; Sun Q; Luo Y
    J Med Chem; 2021 Nov; 64(21):15534-15548. PubMed ID: 34669417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomic basis of CRM1-cargo recognition, release and inhibition.
    Fung HY; Chook YM
    Semin Cancer Biol; 2014 Aug; 27():52-61. PubMed ID: 24631835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRM1 is a direct cellular target of the natural anti-cancer agent plumbagin.
    Liu X; Niu M; Xu X; Cai W; Zeng L; Zhou X; Yu R; Xu K
    J Pharmacol Sci; 2014; 124(4):486-93. PubMed ID: 24739265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of CRM1-NES affinity with nuclear export activity.
    Fu SC; Fung HYJ; Cağatay T; Baumhardt J; Chook YM
    Mol Biol Cell; 2018 Aug; 29(17):2037-2044. PubMed ID: 29927350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Therapy with Nanoparticle-Medicated Intracellular Expression of Peptide CRM1-Inhibitor.
    Sui M; Xiong M; Li Y; Zhou Q; Shen X; Jia D; Gou M; Sun Q
    Int J Nanomedicine; 2021; 16():2833-2847. PubMed ID: 33883894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Guided Design of the First Noncovalent Small-Molecule Inhibitor of CRM1.
    Lei Y; An Q; Shen XF; Sui M; Li C; Jia D; Luo Y; Sun Q
    J Med Chem; 2021 May; 64(10):6596-6607. PubMed ID: 33974430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The myxobacterial metabolite ratjadone A inhibits HIV infection by blocking the Rev/CRM1-mediated nuclear export pathway.
    Fleta-Soriano E; Martinez JP; Hinkelmann B; Gerth K; Washausen P; Diez J; Frank R; Sasse F; Meyerhans A
    Microb Cell Fact; 2014 Jan; 13():17. PubMed ID: 24475978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The export receptor Crm1 forms a dimer to promote nuclear export of HIV RNA.
    Booth DS; Cheng Y; Frankel AD
    Elife; 2014 Dec; 3():e04121. PubMed ID: 25486595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratjadone and leptomycin B block CRM1-dependent nuclear export by identical mechanisms.
    Meissner T; Krause E; Vinkemeier U
    FEBS Lett; 2004 Oct; 576(1-2):27-30. PubMed ID: 15474004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication.
    Lundberg L; Pinkham C; Baer A; Amaya M; Narayanan A; Wagstaff KM; Jans DA; Kehn-Hall K
    Antiviral Res; 2013 Dec; 100(3):662-72. PubMed ID: 24161512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exportin 1 inhibition as antiviral therapy.
    Uddin MH; Zonder JA; Azmi AS
    Drug Discov Today; 2020 Oct; 25(10):1775-1781. PubMed ID: 32569833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear export of proteins and drug resistance in cancer.
    Turner JG; Dawson J; Sullivan DM
    Biochem Pharmacol; 2012 Apr; 83(8):1021-32. PubMed ID: 22209898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Inhibitor of Nuclear Export (SINE) Compounds Alter New World Alphavirus Capsid Localization and Reduce Viral Replication in Mammalian Cells.
    Lundberg L; Pinkham C; de la Fuente C; Brahms A; Shafagati N; Wagstaff KM; Jans DA; Tamir S; Kehn-Hall K
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005122. PubMed ID: 27902702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.